|Bid||2,950.00 x 54200|
|Ask||3,150.00 x 67200|
|Day's Range||2,991.00 - 3,143.00|
|52 Week Range||2,336.50 - 4,265.00|
|Beta (3Y Monthly)||1.63|
|PE Ratio (TTM)||11.61|
|Earnings Date||Feb 20, 2019 - Feb 25, 2019|
|Forward Dividend & Yield||2.03 (6.36%)|
|1y Target Est||3,825.26|
Paul Rawlinson, the head of the international law firm Baker McKenzie, passed away on Friday, the firm said in a statement. Rawlinson, who was 56, was the first UK-based global chair of the firm. “It is with great sadness that we convey to you the news of the unexpected passing of Paul Rawlinson,” a spokesperson said on Monday.
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times Sergio Bucher is to be replaced as ...
The FDA announces it's investigating nearly three dozen cases of people experiencing seizures after vaping. The agency says it's unclear whether e-cigarettes caused the seizures. Tobacco stocks dipped Wednesday after the Food and Drug Administration said it was investigating nearly three dozen cases of people who had seizures after vaping.
The FTSE 250 bounced 1.2 percent - its biggest rise in two-and-a-half months - for a fifth straight session of gains, while the FTSE 100 added 0.4 percent and ended the session at its highest level since early October. Prime Minister Theresa May said on Tuesday said she would seek another Brexit delay beyond April 12, hoping to try to agree a European Union divorce deal with the opposition Labour leader. "None of this guarantees Britain won't bumble out of the EU sans deal, especially given the frothing fury May's cross-party olive branch has caused among the hard right of her Tory party," said Spreadex Analyst Connor Campbell.
The FTSE 100, which earns more than two-thirds of its earnings in U.S. dollars, added 0.6 percent on its best day in a week - and the FTSE 250 was up 0.1 percent. Sterling lost more than a percent as May failed to sway hardline opponents of her European Union divorce deal with an offer to quit, while none of eight indicative options to break the Brexit deadlock won majority support in parliament. Tobacco giant Imperial Brands advanced 2.3 percent and British American Tobacco climbed 2 percent as brokerage Citi hiked rating on both stocks to "Buy" saying regulatory threat will probably move away from cigarettes.
Contrary to conventional wisdom, you don't need a hefty trust fund or deep pockets like mutual funds and other institutional players to start investing.
British American Tobacco PLC put one of Canada’s top cigarette distributors into bankruptcy protection in the U.S. after that subsidiary, sued by Quebec smokers in 1998 for hiding health risks, was ordered to pay 9.2 billion Canadian dollars (US$6.9 billion). Officials who put Imperial Tobacco Canada Ltd. into chapter 15 protection in U.S. Bankruptcy Court in New York said the move is meant stop creditors from taking the tobacco held at the company’s Ohio and Montana warehouses while it negotiates a payment plan. Tobacco for its cigarettes, grown in Mexico, is stored in those warehouses as part of its importing process.
U.S. President Donald Trump's administration has tapped National Cancer Institute Director Norman Sharpless to serve as acting commissioner for the Food and Drug Administration, following the resignation of Scott Gottlieb earlier this month. Sharpless, who has led the National Institutes of Health's cancer unit since 2017, will take over following Gottlieb's exit in April, the U.S. Department of Health and Human Services said on Tuesday.
WINSTON-SALEM, N.C. (AP) — An Ohio manufacturer of electronic cigarettes has accused the R.J. Reynolds Vapor Company of patent infringement.
The FTSE 100 gained for the fourth straight session and closed 0.2 percent higher, while the FTSE 250 was 0.4 percent lower as a weaker pound weighed. British American Tobacco advanced 5.2 percent to a near four-month high and Imperial Brands rose 1.3 percent after U.S. FDA Commissioner Gottlieb, who strove to curb use of flavoured e-cigarettes, said he would step down next month.
U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs. Gottlieb was well regarded by public health advocates and won bipartisan support for his efforts to curb use of flavored e-cigarettes by youths, speed approval times for cheap generic medicines to increase competition and bring down drug prices, and boost the use of cheaper versions of expensive biotech medicines called biosimilars. Unlike his predecessors, who said drug pricing was not the purview of the FDA, Gottlieb waded into the intensifying debate about the high cost of medicines for U.S. consumers and had the agency actively looking into possible solutions.